Evidence map›Paper›PMID 42676453›Full record

ArticleAnnals of vascular diseases2026

Intraoperative Heparin Dose Adjustment in Chronic Limb-Threatening Ischemia Associated with Antiphospholipid Syndrome: A Case Report.

Toru Kikuchi, Yohei Yamamoto, Natsuho Maekawa, Kazuki Tsukuda, Ai Kazama, Yoshiki Wada, Tsuyoshi Ichinose, Toshifumi Kudo

Abstract readCase Reports
In one paragraph

Article in Annals of vascular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Toru KikuchiDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Yohei YamamotoDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Natsuho MaekawaDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Kazuki TsukudaDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Ai KazamaDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Yoshiki WadaDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Tsuyoshi IchinoseDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.
Toshifumi KudoDivision of Vascular Surgery, Department of Cardiovascular Surgery, Institute of Science Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disorder characterized by recurrent arterial and venous thrombosis, as well as pregnancy complications. Laboratory findings often show prolongation of activated partial thromboplastin time, which complicates monitoring during heparin therapy. We present the case of a 69-year-old woman with APS who developed chronic limb-threatening ischemia. She underwent successful bilateral lower-extremity open surgical revascularizations guided by a preoperatively obtained heparin-activated clotting time (ACT) titration curve to define individualized intraoperative anticoagulation targets. This method offered a straightforward and dependable strategy for personalized anticoagulation management and may enhance the safety of peripheral arterial revascularization in patients with APS.

Indexed as

activated clotting timeantiphospholipid syndromechronic limb-threatening ischemia

Identifiers

PMID42676453
PMCPMC13526911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.